Watchlist Price Alert

Ascentage Pharma Group In... (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

28.23

0.26 (0.93%)

At close: Jun 06, 2025, 9:46 AM

Ascentage Pharma International Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q1 2018
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Mar 31, 2018
Cash & Equivalents	1.24B	1.1B	1.07B	1.58B	1.48B	1.7B	1.71B	1.1B	1.02B	430.65M	878.51M	760.9M	957.09M	21.68M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	428.7M	n/a	216.99M	n/a	33.03M	14.4M	28.9M
Long-Term Investments	33.86M	n/a	18.95M	n/a	18.53M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.39M
Other Long-Term Assets	59M	52.5M	10.05M	368.64M	361.93M	38.84M	63.73M	105.05M	82.03M	77.43M	56.72M	52.22M	71.94M	n/a
Receivables	99.07M	852.81M	163.54M	174.22M	61.49M	161.5M	54.13M	66.34M	480K	27.14M	2.53M	2.65M	5.25M	5.03M
Inventory	6.6M	10.72M	16.17M	5.02M	9.45M	5.25M	3.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	24.63M	n/a	24.54M	n/a	16.6M	-80.83M	59.26M	-56M	17.31M	-27.14M	3.95M	8.56M	6.42M	54.99K
Total Current Assets	1.47B	1.96B	1.34B	1.76B	1.64B	1.87B	1.89B	1.6B	1.08B	674.78M	909.11M	829.02M	990.22M	57.3M
Property-Plant & Equipment	905.86M	931.18M	957.23M	633.06M	650.02M	968.46M	854.3M	616.64M	447.88M	258.66M	110.22M	59.61M	33.99M	3.27M
Goodwill & Intangibles	100.69M	104.47M	110.14M	104.8M	109M	115.53M	85.11M	88.47M	122.09M	94.68M	129M	131.2M	133.22M	16.59M
Total Long-Term Assets	1.14B	1.14B	1.16B	1.16B	1.19B	1.17B	1.05B	810.15M	652M	430.76M	295.94M	243.03M	239.16M	29.26M
Total Assets	2.62B	3.11B	2.5B	2.92B	2.83B	3.03B	2.94B	2.41B	1.73B	1.11B	1.21B	1.07B	1.23B	86.56M
Account Payables	91.97M	83.08M	72.44M	47.72M	95.56M	85.73M	70.86M	28.4M	23.36M	11.4M	13.08M	5.35M	5.08M	227.76K
Deferred Revenue	54.09M	n/a	38.41M	n/a	24.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.52K
Short-Term Debt	769.62M	720.1M	606.65M	396M	510.31M	298.93M	39.8M	23.95M	44.75M	62M	85M	100M	35M	n/a
Other Current Liabilities	n/a	37.48M	n/a	24.35M	2.82M	30M	58.73M	25K	16.88M	46K	52.33M	24.92M	24.76M	20.72M
Total Current Liabilities	1.17B	1.07B	934.17M	642.88M	881.15M	612.3M	361.11M	193.79M	276.15M	136.69M	202.06M	175.09M	105.27M	22.15M
Long-Term Debt	868.64M	959.14M	1.17B	1.26B	1.27B	1.24B	1.03B	622.54M	473.06M	212.86M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.27M	18.8M	18.3M	185.31M	35.33M	52.63M	52.34M	75.97M	73.57M	82.45M	51.25M	2.46B	2.09B	91.26M
Total Long-Term Liabilities	1.18B	1.27B	1.5B	1.68B	1.54B	1.55B	1.34B	764.52M	608.27M	356.64M	112.51M	2.52B	2.14B	94.77M
Total Liabilities	2.34B	2.33B	2.43B	2.32B	2.42B	2.16B	1.71B	958.31M	884.42M	493.33M	314.57M	2.7B	2.24B	116.92M
Total Debt	1.67B	1.7B	1.8B	1.68B	1.79B	1.56B	1.08B	667.41M	529.7M	288.08M	101.41M	120.11M	42.04M	n/a
Common Stock	214K	214K	197K	196K	180K	179K	178K	172K	154K	142K	142K	63K	63K	n/a
Retained Earnings	-5.77B	-5.2B	-5.37B	-4.84B	-4.44B	n/a	-3.56B	n/a	-2.77B	-2.42B	-2.1B	n/a	-615.82M	-45.01M
Comprehensive Income	-510.59M	n/a	-504.46M	n/a	-518.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.4M
Shareholders Equity	264.19M	766.4M	60.42M	589.89M	408.66M	876.85M	1.23B	1.45B	846.62M	612.21M	890.48M	-1.62B	-1.01B	-32.61M
Total Investments	33.86M	33.2M	18.95M	18.66M	18.53M	21.1M	27.84M	29.86M	31.77M	39.33M	32.19M	34.83M	59.52M	38.29M